Intrinsiqs

Is Myriad Genetics, Inc. overvalued?

Myriad Genetics, Inc. (MYGN) — key valuation metrics and fundamentals.

No verdict
Price
$3.03
Fair value
Current P/E
Normal P/E
19.8
Market cap
$286.2M
Dividend yield
108.7%
Return on equity
-32.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MYGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.